ESOPHAGUS CANCER
Clinical trials for ESOPHAGUS CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGUS CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGUS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy plus chemoradiation shows promise in Hard-to-Treat esophageal cancer
Disease control CompletedThis study tested whether adding the immunotherapy drug durvalumab to standard chemoradiation helps people with esophageal cancer that cannot be removed by surgery. 112 patients took part. The main goal was to see if the combination slowed cancer growth or improved survival. Whil…
Matched conditions: ESOPHAGUS CANCER
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 26, 2026 06:01 UTC
-
New drug CBX-12 tested for Tough-to-Treat cancers
Disease control CompletedThis study tested a new drug called CBX-12 in 69 adults with advanced solid tumors (like ovarian, lung, breast, or colon cancer) that had stopped responding to standard treatments. The goal was to find a safe dose and see if the drug could shrink tumors. The study was completed, …
Matched conditions: ESOPHAGUS CANCER
Phase: PHASE1, PHASE2 • Sponsor: Cybrexa Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:37 UTC